[End to side porto-caval shunt in familial type II homozygote hypercholesterolemia (author's transl)].
Two patients with homozygous type II familial hypercholemia have had significant improvement by end to side porta-caval shunt. Follow-up is respectively 1 and 4 years. When all the other treatment have failed in lowering blood cholesterol and L.D.L. levels, a portal diversion may help to prevent cardio-vascular atherosclerotic complications in the pediatric age.
D001161:Arteriosclerosis / Q000517:prevention & control; D001166:Arteriovenous Shunt, Surgical; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000601:surgery*; D011169:Portal Vein / Q000601:surgery*; D014682:Vena Cava, Inferior / Q000601:surgery
L'anastomose porto-cave termino-latérale dans l'hypercholestérolémie familiae de type II homozygote.